Page last updated: 2024-11-05

trimethoprim and Mitochondrial Myopathies

trimethoprim has been researched along with Mitochondrial Myopathies in 1 studies

Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.

Mitochondrial Myopathies: A group of muscle diseases associated with abnormal mitochondria function.

Research Excerpts

ExcerptRelevanceReference
" Here we describe the occurrence of severe combined immunodeficiency (SCID) with megaloblastic anemia, leukopenia, atypical hemolytic uremic syndrome, and neurologic abnormalities in which hydroxocobalamin and folate therapy provided partial immune reconstitution."3.79Severe combined immunodeficiency resulting from mutations in MTHFD1. ( Baluarte, HJ; Bergqvist, AG; Ganesh, J; Heltzer, M; Keller, MD; Orange, JS; Paessler, M; Rosenblatt, DS; Watkins, D, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Keller, MD1
Ganesh, J1
Heltzer, M1
Paessler, M1
Bergqvist, AG1
Baluarte, HJ1
Watkins, D1
Rosenblatt, DS1
Orange, JS1

Other Studies

1 other study available for trimethoprim and Mitochondrial Myopathies

ArticleYear
Severe combined immunodeficiency resulting from mutations in MTHFD1.
    Pediatrics, 2013, Volume: 131, Issue:2

    Topics: 3-Hydroxyacyl CoA Dehydrogenases; Anemia, Megaloblastic; Bone Marrow Examination; Cardiomyopathies;

2013